KURA

$0.00

(

0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Kura Oncology Inc

NASDAQ | KURA

9.58

USD

$0.00

(

0.00%

)

At Close (As of Oct 21, 2025)

$867.10M

Market Cap

-

P/E Ratio

-2.25

EPS

$19.73

52 Week High

$5.41

52 Week Low

HEALTHCARE

Sector

KURA Chart

Recent Chart
Price Action

KURA Technicals

Tags:

KURA Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $53M
Total Revenue $54M
Cost Of Revenue $848K
Costof Goods And Services Sold $848K
Operating Income -$193M
Selling General And Administrative $77M
Research And Development $170M
Operating Expenses $247M
Investment Income Net -
Net Interest Income $21M
Interest Income $23M
Interest Expense $1.6M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $848K
Income Before Tax -$172M
Income Tax Expense $2M
Interest And Debt Expense -
Net Income From Continuing Operations -$174M
Comprehensive Income Net Of Tax -
Ebit -$170M
Ebitda -$169M
Net Income -$174M

Revenue & Profitability

Earnings Performance

KURA Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $760M
Total Current Assets $745M
Cash And Cash Equivalents At Carrying Value $224M
Cash And Short Term Investments $224M
Inventory -
Current Net Receivables $6.1M
Total Non Current Assets $15M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets -
Intangible Assets Excluding Goodwill -
Goodwill -
Investments -
Long Term Investments -
Short Term Investments $503M
Other Current Assets $11M
Other Non Current Assets -
Total Liabilities $347M
Total Current Liabilities $79M
Current Accounts Payable $1.5M
Deferred Revenue -
Current Debt -
Short Term Debt $6.4M
Total Non Current Liabilities $268M
Capital Lease Obligations $7.1M
Long Term Debt $6.9M
Current Long Term Debt $2.6M
Long Term Debt Noncurrent -
Short Long Term Debt Total $17M
Other Current Liabilities $69M
Other Non Current Liabilities $1.8M
Total Shareholder Equity $414M
Treasury Stock -
Retained Earnings -$895M
Common Stock $8K
Common Stock Shares Outstanding $86M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $134M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $848K
Capital Expenditures $472K
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$102M
Cashflow From Financing $154M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$174M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $53M
Total Revenue $54M
Cost Of Revenue $848K
Costof Goods And Services Sold $848K
Operating Income -$193M
Selling General And Administrative $77M
Research And Development $170M
Operating Expenses $247M
Investment Income Net -
Net Interest Income $21M
Interest Income $23M
Interest Expense $1.6M
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $848K
Income Before Tax -$172M
Income Tax Expense $2M
Interest And Debt Expense -
Net Income From Continuing Operations -$174M
Comprehensive Income Net Of Tax -
Ebit -$170M
Ebitda -$169M
Net Income -$174M

KURA News

KURA Profile

Kura Oncology Inc Profile

Sector: HEALTHCARE

Industry: BIOTECHNOLOGY

Kura Oncology, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, focused on the discovery and development of innovative therapies for genetically defined tumors in oncology. With a robust pipeline of targeted treatment candidates, Kura aims to address significant unmet medical needs in cancer care. The company's dedication to rigorous clinical development, bolstered by strategic partnerships, positions it to deliver transformative therapeutic options and enhance patient outcomes worldwide.

BYND
+146.25%
$3.62
VHAI
0.00%
$0.00
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
NVDA
-0.81%
$181.16
GDXD
+28.69%
$0.86
AIRE
+61.36%
$0.72
BURU
-14.84%
$0.28
BITF
-9.83%
$4.49
PLUG
-8.23%
$3.12
ADAP
-17.62%
$0.04
T
-0.19%
$26.05
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
DNN
-7.16%
$2.72
BTG
-9.12%
$5.18
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.24%
$13.39
DVLT
+4.54%
$2.52
IBIO
+24.30%
$1.11
RIG
+0.60%
$3.31
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
ETHD
-0.80%
$3.72
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
AMZN
+2.56%
$222.03
GRAB
-1.23%
$5.60
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
ACHR
-4.75%
$11.41
LAES
-5.86%
$6.10
IONZ
+1.48%
$4.11
GM
+14.86%
$66.62
RR
+1.25%
$5.63
SOUN
-4.35%
$18.23
BTBT
-8.29%
$3.87
VALE
-1.14%
$11.27
BBD
-2.36%
$3.30
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
MARA
-3.18%
$20.07
IREN
-6.79%
$55.19
RMBL
+60.50%
$3.21
DCGO
+24.16%
$1.49
HAL
+11.58%
$25.24
CJET
-20.45%
$0.08
AAL
+1.47%
$12.35
DFLI
-3.96%
$1.21
ADD
-25.47%
$0.05
GPUS
-7.57%
$0.36
CLSK
-7.99%
$18.77
NOK
-2.27%
$5.58
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
AMC
+4.33%
$2.89
KO
+4.06%
$71.22
PBR
-1.11%
$11.56
SNAP
+1.55%
$7.85
ONDS
-7.46%
$7.19
SMR
-13.20%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
SMCI
-0.39%
$54.82
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.83%
$152.00
RIVN
+0.91%
$13.20
GOOG
-2.20%
$251.34
PLTR
-0.04%
$181.51
BAC
-0.99%
$51.52
APLD
-9.35%
$32.54
EPWK
-8.71%
$0.07
RGTZ
+15.11%
$15.61
ETWO
0.00%
$3.30
MSN
+59.31%
$0.76
BULL
-2.96%
$11.14
IONQ
-0.73%
$59.50
WTO
+2.93%
$0.06
KVUE
-0.20%
$14.93
BYND
+146.25%
$3.62
VHAI
0.00%
$0.00
YDKG
+27.99%
$0.05
YYAI
-19.18%
$0.08
F
+4.75%
$12.56
VSEE
+93.56%
$0.94
CGBS
-39.47%
$0.03
NERV
+140.97%
$6.41
RANI
+26.66%
$2.85
NVDA
-0.81%
$181.16
GDXD
+28.69%
$0.86
AIRE
+61.36%
$0.72
BURU
-14.84%
$0.28
BITF
-9.83%
$4.49
PLUG
-8.23%
$3.12
ADAP
-17.62%
$0.04
T
-0.19%
$26.05
RGTI
-7.64%
$40.00
HPE
+1.74%
$23.27
CAN
-4.87%
$1.95
DNN
-7.16%
$2.72
BTG
-9.12%
$5.18
INTC
+0.05%
$38.11
WBD
+10.97%
$20.32
BOF
+33.65%
$2.80
JOBY
-7.63%
$16.10
AXDX
-61.36%
$0.03
CLF
-17.24%
$13.39
DVLT
+4.54%
$2.52
IBIO
+24.30%
$1.11
RIG
+0.60%
$3.31
GSIT
-16.26%
$10.86
TLRY
-5.73%
$1.48
NVTS
-12.10%
$15.03
RXRX
-8.53%
$6.11
ETHD
-0.80%
$3.72
SOFI
+0.24%
$28.75
ABEV
-2.20%
$2.22
TSLA
-1.07%
$442.60
RF
+1.24%
$24.36
AMZN
+2.56%
$222.03
GRAB
-1.23%
$5.60
AMD
-1.05%
$238.03
AAPL
+0.20%
$262.77
GOOGL
-2.37%
$250.46
QUBT
-7.40%
$16.00
ACHR
-4.75%
$11.41
LAES
-5.86%
$6.10
IONZ
+1.48%
$4.11
GM
+14.86%
$66.62
RR
+1.25%
$5.63
SOUN
-4.35%
$18.23
BTBT
-8.29%
$3.87
VALE
-1.14%
$11.27
BBD
-2.36%
$3.30
PFE
+0.64%
$24.85
QBTS
-6.42%
$32.19
MARA
-3.18%
$20.07
IREN
-6.79%
$55.19
RMBL
+60.50%
$3.21
DCGO
+24.16%
$1.49
HAL
+11.58%
$25.24
CJET
-20.45%
$0.08
AAL
+1.47%
$12.35
DFLI
-3.96%
$1.21
ADD
-25.47%
$0.05
GPUS
-7.57%
$0.36
CLSK
-7.99%
$18.77
NOK
-2.27%
$5.58
NIO
-3.68%
$6.80
SRM
+53.27%
$10.30
CIFR
-9.21%
$18.07
BMNR
-3.62%
$51.85
AMC
+4.33%
$2.89
KO
+4.06%
$71.22
PBR
-1.11%
$11.56
SNAP
+1.55%
$7.85
ONDS
-7.46%
$7.19
SMR
-13.20%
$38.36
HBAN
+0.63%
$15.94
VZ
-1.23%
$40.29
HIMS
-3.89%
$49.36
CUTR
-10.19%
$0.09
SMCI
-0.39%
$54.82
GGB
-1.17%
$3.37
WLGS
-5.57%
$0.04
PM
-3.83%
$152.00
RIVN
+0.91%
$13.20
GOOG
-2.20%
$251.34
PLTR
-0.04%
$181.51
BAC
-0.99%
$51.52
APLD
-9.35%
$32.54
EPWK
-8.71%
$0.07
RGTZ
+15.11%
$15.61
ETWO
0.00%
$3.30
MSN
+59.31%
$0.76
BULL
-2.96%
$11.14
IONQ
-0.73%
$59.50
WTO
+2.93%
$0.06
KVUE
-0.20%
$14.93
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.